Dixon AS - Search Results

1

Split-enzyme immunoassay to monitor EGFR-HER2 heterodimerization on cell surfaces.

Kim SJ, Dixon AS, Owen SC. Kim SJ, et al. Among authors: dixon as. Acta Biomater. 2021 Nov;135:225-233. doi: 10.1016/j.actbio.2021.08.055. Epub 2021 Sep 5. Acta Biomater. 2021. PMID: 34496282

2

Homogeneous Immunoassay Using a Tri-Part Split-Luciferase for Rapid Quantification of Anti-TNF Therapeutic Antibodies.

Kim SJ, Dixon AS, Adamovich PC, Robinson PD, Owen SC. Kim SJ, et al. Among authors: dixon as. ACS Sens. 2021 May 28;6(5):1807-1814. doi: 10.1021/acssensors.0c02642. Epub 2021 May 19. ACS Sens. 2021. PMID: 34010570

3

A Tri-part Protein Complementation System Using Antibody-Small Peptide Fusions Enables Homogeneous Immunoassays.

Dixon AS, Kim SJ, Baumgartner BK, Krippner S, Owen SC. Dixon AS, et al. Sci Rep. 2017 Aug 15;7(1):8186. doi: 10.1038/s41598-017-07569-y. Sci Rep. 2017. PMID: 28811487 Free PMC article.

4

Split-enzyme fragment as a single affinity tag that enables protein expression, purification, and functional assays.

Kim SJ, Hatch ST, Dixon AS, Owen SC. Kim SJ, et al. Among authors: dixon as. Biotechnol Bioeng. 2019 Jul;116(7):1575-1583. doi: 10.1002/bit.26980. Epub 2019 Apr 17. Biotechnol Bioeng. 2019. PMID: 30934115

5

Multivalent HER2-binding polymer conjugates facilitate rapid endocytosis and enhance intracellular drug delivery.

Radford DC, Yang J, Doan MC, Li L, Dixon AS, Owen SC, Kopeček J. Radford DC, et al. Among authors: dixon as. J Control Release. 2020 Mar 10;319:285-299. doi: 10.1016/j.jconrel.2019.12.049. Epub 2019 Dec 30. J Control Release. 2020. PMID: 31899273

6

CRISPR-Mediated Tagging of Endogenous Proteins with a Luminescent Peptide.

Schwinn MK, Machleidt T, Zimmerman K, Eggers CT, Dixon AS, Hurst R, Hall MP, Encell LP, Binkowski BF, Wood KV. Schwinn MK, et al. Among authors: dixon as. ACS Chem Biol. 2018 Feb 16;13(2):467-474. doi: 10.1021/acschembio.7b00549. Epub 2017 Sep 21. ACS Chem Biol. 2018. PMID: 28892606 Free article.

7

The nuclear translocation assay for intracellular protein-protein interactions and its application to the Bcr coiled-coil domain.

Dixon AS, Lim CS. Dixon AS, et al. Biotechniques. 2010 Jul;49(1):519-24. doi: 10.2144/000113452. Biotechniques. 2010. PMID: 20615205 Free PMC article.

8

Disruption of Bcr-Abl coiled coil oligomerization by design.

Dixon AS, Pendley SS, Bruno BJ, Woessner DW, Shimpi AA, Cheatham TE 3rd, Lim CS. Dixon AS, et al. J Biol Chem. 2011 Aug 5;286(31):27751-60. doi: 10.1074/jbc.M111.264903. Epub 2011 Jun 9. J Biol Chem. 2011. PMID: 21659527 Free PMC article.

9

Improved coiled-coil design enhances interaction with Bcr-Abl and induces apoptosis.

Dixon AS, Miller GD, Bruno BJ, Constance JE, Woessner DW, Fidler TP, Robertson JC, Cheatham TE 3rd, Lim CS. Dixon AS, et al. Mol Pharm. 2012 Jan 1;9(1):187-95. doi: 10.1021/mp200461s. Epub 2011 Dec 12. Mol Pharm. 2012. PMID: 22136227 Free PMC article.

10

A chimeric p53 evades mutant p53 transdominant inhibition in cancer cells.

Okal A, Mossalam M, Matissek KJ, Dixon AS, Moos PJ, Lim CS. Okal A, et al. Among authors: dixon as. Mol Pharm. 2013 Oct 7;10(10):3922-33. doi: 10.1021/mp400379c. Epub 2013 Sep 9. Mol Pharm. 2013. PMID: 23964676

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

142 results

Search Page